NeuroOne Medical Technologies Co. (NASDAQ:NMTC) CFO Acquires $100,000.00 in Stock

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) CFO Ronald W. Mcclurg purchased 200,000 shares of NeuroOne Medical Technologies stock in a transaction dated Friday, April 4th. The shares were purchased at an average cost of $0.50 per share, with a total value of $100,000.00. Following the acquisition, the chief financial officer now owns 444,117 shares of the company’s stock, valued at approximately $222,058.50. This trade represents a 81.93 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

NeuroOne Medical Technologies Stock Down 8.8 %

NMTC stock opened at $0.43 on Tuesday. The stock has a market cap of $13.37 million, a PE ratio of -1.67 and a beta of 0.61. The firm’s 50-day simple moving average is $1.02 and its 200 day simple moving average is $0.93. NeuroOne Medical Technologies Co. has a fifty-two week low of $0.41 and a fifty-two week high of $1.39.

NeuroOne Medical Technologies (NASDAQ:NMTC) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.06 EPS for the quarter. NeuroOne Medical Technologies had a negative net margin of 82.17% and a negative return on equity of 270.70%.

Institutional Trading of NeuroOne Medical Technologies

Hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in shares of NeuroOne Medical Technologies in the fourth quarter worth $33,000. Geode Capital Management LLC lifted its holdings in NeuroOne Medical Technologies by 9.8% in the fourth quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock worth $257,000 after purchasing an additional 27,804 shares during the period. Finally, XTX Topco Ltd bought a new position in NeuroOne Medical Technologies in the 3rd quarter valued at about $26,000. Institutional investors own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.